3 results
The primary objective is to determine the pharmacokinetic characteristics of galantamine after 2 single oral doses in children with Down syndrome. Secondary objectives are to evaluate safety and tolerability.
The primary objective of this study will be to determine the pharmacokinetic profile of lorazepam oral liquid 1 mg/ml in the paediatric ICU population, with specific attention for the population aged up to 12 years of age.The secondary objectives…
Primary Objective: To confirm that the lithium headcoil is capable of measuring lithium signals related to clinical doses in the brains of BD patients (MDR, art 82), and then to establish the correlation of neuroimaging data of lithium…